Basic Info.
Semaglutide is a GLP-1 receptor agonist (incretin mimetic) used to treat type 2 diabetes and obesity. It stimulates insulin release, suppresses glucagon secretion, slows gastric emptying, and reduces appetite.
Administered once weekly via subcutaneous injection, it helps lower blood sugar and promote weight loss.
Our factory
“Strength builds the foundation, and excellent services reach all over the world.” Create win-win situation with customers
Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.